Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil by Yared Santa-Ana-Tellez et al.
ORAL PRESENTATION Open Access
Price changes of antibiotics and perceived
substitutes in the context of OTC policy changes
in Mexico and Brazil
Yared Santa-Ana-Tellez1, Veronika J Wirtz2,3, Hubert GM Leufkens1, Aukje K Mantel-Teeuwisse1*
From 3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Chal-
lenges Beyond the Financial Crisis
Vienna, Austria. 12-13 October 2015
Problem statement
The over-the-counter (OTC) sales restriction of antibiotics
in Mexico and Brazil might have created incentives to
maintain the sales revenue by increasing antibiotics prices
and attract the consumption of substitutes by decreasing
their price.
Objectives
To explore price changes of antibiotics and their substi-
tutes in Mexico and Brazil.
Policies targeted: Over-the-counter sales restriction of
antibiotics in Mexico and Brazil.
Stakeholders: Governments of Mexico and Brazil.




Time period: January 2008-March 2013.
Setting: IMS Health retail quarterly trade prices from the
private sectors in Mexico and Brazil. Groups studied were:
antibiotics, cough-and-cold medicines, non-steroidal anti-
inflammatory drugs (NSAIDs), and analgesics. The latter
two groups were combined in the analysis of median price
per defined daily dose (DDD). All prices were adjusted for
inflation rate and converted to US Dollars.
Interventions: Interrupted time series analysis to
measure price changes (level and slope) after the OTC
sales regulation of antibiotics and seasonal price
changes. Stationarity and autocorrelation corrected
using ARIMA models.
Results
After the regulation in Mexico the median price of anti-
biotics increased by $0.6 per DDD (p<0.001, level increase)
with a slope decrease of $0.21 per quarter (p<0.001),
NSAIDs-analgesics prices decreased by $0.11 (p=0.04)
with a slope increase of $0.02 (p=0.002) per quarter, and
prices of cough-and-cold medicines increased by $0.36
(p=0.006). In Brazil prices of antibiotics did not change
after the regulation, NSAIDs-analgesics median price
increased by $0.04 (p<0.00) with a slope decrease of $0.01
(p=0.001) per quarter, and cough-and-cold medicines
price slope increased by $0.02 (p<0.00) per quarter. For
both countries we observed seasonal variation in prices
with highest prices during warm seasons where use is rela-
tively low (spring and summer). The difference in price of
antibiotics between winter and summer was $1.5
(p<0.001) in Mexico and $0.31 (p=0.02) in Brazil, and for
cough-and-cold medicines this difference was $3.07
(p<0.001) in Mexico and $0.58 (p<0.001) in Brazil. The
difference in price of NSAIDs-analgesics between winter
and autumn in Mexico was $0.17 (p<0.001) and in Brazil
was $0.09 (p<0.001).
Conclusions
After the regulation in Mexico prices of antibiotics
increased while prices of NSAIDs-analgesics decreased.
In Brazil NSAIDs-analgesics prices increased. However
these changes were outweighed by the seasonal variation
in prices.
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Lessons learned and success factors
Possible effects on prices need to be considered when
designing and implementing pharmaceutical polices, to
anticipate or prevent unintended outcomes.
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